Optimising Outcomes with Intra-Articular Therapies in Knee OA
While clinical guidelines provide a useful framework for managing knee osteoarthritis (OA), translating these recommendations into day-to-day clinical practice is often less straightforward.
In reality, treatment decisions are shaped not only by evidence, but also by:
- Individual patient characteristics
- Symptom patterns
- Clinical experience
Among non-surgical options, intra-articular injections, such as viscosupplements or steroids remain widely used. However, outcomes can vary, and small differences in approach can have a meaningful impact on results.
This blog focuses on practical considerations that can help optimise outcomes, drawing on common challenges observed in routine clinical care for knee osteoarthritis.
Moving beyond criteria: applying patient selection in practice
Guidelines often highlight general characteristics of suitable patients, but in clinic, decisions are rarely black and white. Recommendations vary across major organisations, reflecting differences in how evidence is interpreted and applied in practice.1,2
In practice, clinicians may encounter patients who sit “in-between” categories, for example:
- Moderate radiographic changes but significant pain
- Predominantly mechanical symptoms with intermittent inflammation
- Active patients seeking to maintain function rather than simply reduce pain
In these scenarios, decision-making often comes down to:
- The primary driver of symptoms (inflammatory vs mechanical)
- Patient expectations
- Previous treatment response
Equally important is recognising when not to treat, even if basic criteria are met – for example, in patients with:
- Advanced structural changes unlikely to respond
- Unrealistic expectations of treatment outcomes
Common pitfalls in clinical practice
Even when patient selection is appropriate, several factors can limit treatment effectiveness:
- Treating too late in the disease pathway
Patients with advanced osteoarthritis may be less responsive to intra-articular injections, particularly where structural damage predominates1 - Misalignment between treatment and symptom profile
Treatments that primarily address inflammation may not perform as expected in patients with predominantly mechanical symptoms, and vice versa - Inadequate expectation setting
Patients anticipating immediate or complete relief may perceive treatment as ineffective, even when clinically meaningful improvement occurs - Over-reliance on a single intervention
Intra-articular injections should be considered as part of a broader management strategy, rather than a standalone solution1
Practical considerations for injection
While injection technique is often well established, small details can influence outcomes:
- Ensuring accurate intra-articular placement remains critical
- Consistency in technique can improve reproducibility of results
- For some clinicians, image guidance may support accuracy, particularly in more challenging cases
In addition, attention to:
- Patient positioning
- Joint effusion (if present)
- Overall procedural consistency
can contribute to more predictable outcomes.
Managing patient expectations
A key determinant of perceived success is how well expectations are explained before treatment.
Patients should understand that:
- Symptom relief may not be immediate in all cases
- The degree and duration of response can vary1
- The goal is often improvement in function and quality of life, rather than complete symptom resolution
Clear communication helps:
- Improve patient satisfaction
- Reduce premature judgement of treatment failure
- Support more appropriate follow-up decisions
Assessing response and planning next steps
Follow-up is an essential but sometimes overlooked aspect of care.
Clinicians may consider:
- Timing of reassessment
- Functional improvement (not just pain scores)
- Duration of response
This allows for more informed decisions regarding:
- Repeat treatment
- Alternative approaches
- Progression along the treatment pathway
Balancing onset and durability in treatment choice
One of the practical challenges in knee OA management is addressing both rapid symptom relief and sustained functional improvement. While clinical guidelines provide a useful framework, they also highlight variability in how intra-articular therapies are positioned, reinforcing the need for individualised decision-making.1,2
In practice, different intra-articular therapies may emphasise one of these aspects more than the other. Corticosteroids are typically associated with a faster onset of pain relief, particularly in patients with inflammatory symptoms, whereas hyaluronic acid may offer more sustained improvement over time, particularly in appropriately selected patients.3
This distinction is clinically important when aligning treatment choice with patient needs. Patients presenting with acute pain or inflammation may prioritise rapid relief, while others may benefit more from approaches aimed at longer-term functional improvement. As a result, there is increasing interest in strategies that better balance these competing priorities, reflecting a broader shift towards more tailored and mechanism-aligned treatment approaches in knee OA management.1
Conclusion
Optimising outcomes with intra-articular therapies in knee osteoarthritis extends beyond guideline recommendations.
In practice, success is often influenced by:
- Nuanced patient selection
- Attention to technique
- Clear communication with patients
- Ongoing assessment and adjustment of the treatment plan
As clinical approaches continue to evolve, there is increasing value in moving from protocol-driven decisions towards individualised, experience-informed care, aimed at achieving meaningful improvements in patient outcomes.
